# Takeda Pharmaceutical Company Limited (TAK)

> Healthcare · JP · Reports in JPY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TAK/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 4,486.09B | ¥ 114.75B | ¥ 826.86B | ¥ 4,856.63B | ¥ 7,648.16B |
| 2024 | ¥ 4,579.02B | ¥ 208.07B | ¥ 704.75B | ¥ 4,840.15B | ¥ 7,418.27B |
| 2023 | ¥ 4,169.05B | ¥ 178.22B | ¥ -109.42B | ¥ 4,664.16B | ¥ 6,741.93B |
| 2022 | ¥ 3,944.61B | ¥ 274.53B | ¥ 864.80B | ¥ 4,286.90B | ¥ 6,175.98B |
| 2021 | ¥ 3,465.99B | ¥ 438.52B | ¥ 1,269.33B | ¥ 4,354.88B | ¥ 5,331.33B |
| 2020 | ¥ 3,176.96B | ¥ 179.37B | ¥ 925.36B | ¥ 4,751.05B | ¥ 4,635.35B |
| 2019 | ¥ 3,175.78B | ¥ -53.32B | ¥ -357.14B | ¥ 5,221.75B | ¥ 4,872.07B |
| 2018 | ¥ 1,761.48B | ¥ 109.21B | ¥ -1,369.65B | ¥ 2,548.78B | ¥ 2,038.68B |
| 2017 | ¥ 1,771.55B | ¥ 188.66B | ¥ -223.12B | ¥ 1,138.47B | ¥ 2,113.89B |
| 2016 | ¥ 1,733.63B | ¥ 132.47B | ¥ -20.19B | ¥ 975.90B | ¥ 1,981.58B |
| 2015 | ¥ 1,840.59B | ¥ -112.45B | ¥ 92.67B | ¥ 730.12B | ¥ 2,098.86B |
| 2014 | ¥ 1,757.42B | ¥ 75.95B | ¥ 345.61B | ¥ 912.88B | ¥ 2,503.48B |
| 2013 | ¥ 1,707.10B | ¥ 122.48B | ¥ -103.60B | ¥ 791.50B | ¥ 2,382.90B |
| 2012 | ¥ 1,645.68B | ¥ 107.38B | ¥ 0 | ¥ 541.88B | ¥ 2,062.16B |
| 2011 | ¥ 1,532.84B | ¥ 201.80B | ¥ 118.05B | ¥ 541.26B | ¥ 1,917.17B |
| 2010 | ¥ 1,480.85B | ¥ 265.13B | ¥ 176.90B | ¥ 3.20B | ¥ 2,048.16B |
| 2009 | ¥ 1,522.32B | ¥ 338.02B | ¥ 374.09B | ¥ 3.27B | ¥ 2,063.66B |
| 2008 | ¥ 824.34B | ¥ 169.88B | ¥ 63.25B | ¥ 3.70B | ¥ 1,876.91B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.64 |
| Liabilities / Eq | 1.02 |
| Current Ratio | 1.19 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 27.43 |
| Gross Debt / FCF | 19.34 |

## Other views

- [Metrics](https://sponda.capital/en/TAK.md)
- [Charts](https://sponda.capital/en/TAK/charts.md)
- [Compare](https://sponda.capital/en/TAK/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.